Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

341 ARTÍCULOS , VIENDO DEL 166 AL 180

Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections

Samotus O, Lee J, Jog M.

PLoS One. 2017 Jun 6;12(6):e0178670. doi: 10.1371/journal.pone.0178670. eCollection 2017.

Four Cases of Parkinson Disease Diagnosed During the Postpartum Period

Maltête D, Grangeon L, Le Goff F, Ozel G, Fetter D, Ahtoy P, Temgoua O, Rouillé A, Lefaucheur R.

Obstet Gynecol. 2017 Jul;130(1):203-206. doi: 10.1097/AOG.0000000000002066.

Adaptive Deep Brain Stimulation for Movement Disorders: The Long Road to Clinical Therapy

Meidahl AC, Tinkhauser G, Herz DM, Cagnan H, Debarros J, Brown P.

Mov Disord. 2017 Jun;32(6):810-819. doi: 10.1002/mds.27022.

Multifactorial sleep disturbance in Parkinson's disease

Albers JA, Chand P, Anch AM.

Sleep Med. 2017 Jul;35:41-48. doi: 10.1016/j.sleep.2017.03.026. Epub 2017 Apr 25.

Neurodegenerative signaling factors and mechanisms in Parkinson's pathology

Goswami P, Joshi N, Singh S.

Toxicol In Vitro. 2017 Sep;43:104-112. doi: 10.1016/j.tiv.2017.06.008. Epub 2017 Jun 13.

Structural connectivity differences in motor network between tremor-dominant and nontremor Parkinson's disease

Barbagallo G, Caligiuri ME, Arabia G, Cherubini A, Lupo A, Nisticò R, Salsone M, Novellino F, Morelli M, Cascini GL, Galea D, Quattrone A.

Hum Brain Mapp. 2017 Sep;38(9):4716-4729. doi: 10.1002/hbm.23697. Epub 2017 Jun 20.

Thalamic deep brain stimulation for orthostatic tremor: A multicenter international registry

Merola A, Fasano A, Hassan A, Ostrem JL, Contarino MF, Lyons M, Krauss JK, Wolf ME, Klassen BT, van Rootselaar AF, Regidor I, Duker AP, Ondo W, Guridi J, Volkmann J, Wagle Shukla A, Mandybur GT, Okun MS, Witt K, Starr PA, Deuschl G, Espay AJ.

Mov Disord. 2017 Aug;32(8):1240-1244. doi: 10.1002/mds.27082. Epub 2017 Jun 20.

Serum Ceruloplasmin and Striatal Dopamine Transporter Density in Parkinson Disease: Comparison With 123I-FP-CIT SPECT

Song YS, Kim JM, Kim KJ, Yun JY, Kim SE.

Clin Nucl Med. 2017 Sep;42(9):675-679. doi: 10.1097/RLU.0000000000001734.

Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis

Shafieesabet A, Fereshtehnejad SM, Shafieesabet A, Delbari A, Baradaran HR, Postuma RB, Lökk J.

Parkinsonism Relat Disord. 2017 Sep;42:1-11. doi: 10.1016/j.parkreldis.2017.06.006. Epub 2017 Jun 15.

Latent Cognitive Phenotypes in De Novo Parkinson's Disease: A Person-Centered Approach

LaBelle DR, Walsh RR, Banks SJ.

J Int Neuropsychol Soc. 2017 Aug;23(7):551-563. doi: 10.1017/S1355617717000406. Epub 2017 Jun 27.

Gender differences in Parkinson's disease: A clinical perspective

Georgiev D, Hamberg K, Hariz M, Forsgren L, Hariz GM.

Acta Neurol Scand. 2017 Dec;136(6):570-584. doi: 10.1111/ane.12796. Epub 2017 Jul 2.

A Novel p.Glu298Lys Mutation in the ACMSD Gene in Sporadic Parkinson's Disease

Vilas D, Fernández-Santiago R, Sanchez E, Azcona LJ, Santos-Montes M, Casquero P, Argandoña L, Tolosa E, Paisán-Ruiz C.

J Parkinsons Dis. 2017;7(3):459-463. doi: 10.3233/JPD-171146.

Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease

Miyazaki I, Asanuma M.

Curr Pharm Des. 2017;23(33):4936-4947. doi: 10.2174/1381612823666170710163731.

Nonmotor fluctuations: phenotypes, pathophysiology, management, and open issues

Classen J, Koschel J, Oehlwein C, Seppi K, Urban P, Winkler C, Wüllner U, Storch A.

J Neural Transm (Vienna). 2017 Aug;124(8):1029-1036. doi: 10.1007/s00702-017-1757-0. Epub 2017 Jul 12.

Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden

Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW.

Am J Manag Care. 2017 Apr;23(5 Suppl):S83-S92.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias